Our Story
Built on the vision of better patient outcomes, Instapath was founded by engineers and scientists to enable patients to immediately know their cancer diagnosis.
With complex, time-consuming tissue preparation and evaluation, patients face anxiety while waiting for their pathology results and lifesaving cancer treatments can be delayed for patients with progressive cancer. We knew there had to be a better path to improved patient outcomes, so our team made it our mission to develop fast and easy digital pathology technology so diagnosis can be made in minutes instead of days. After years of research in academia and with our research prototype in hand, we founded Instapath in 2017 to make our technology available to researchers and physicians around the world.
If you are interested in joining our team, email our CEO at mei@instapathbio.com
Our Team

Mei Wang, Ph.D.

Chief Executive Officer

David Tulman, Ph.D.

Chief Clinical Officer

J. Quincy Brown, Ph.D.

Chief Research Officer

Tom Szymczyk

Embedded Systems Engineer

Sam Luethy

Product Engineer

Kristin Mitchener

Marketing Coordinator

Andrew B. Sholl, M.D.

Advisor

Neil Ninan, M.D., M.B.A.

Advisor

Eric Buckland, Ph.D.

Advisor

Supported by